New hope for advanced cancers: BHV-1510 trial launches

NCT ID NCT06384807

First seen Nov 17, 2025 · Last updated May 20, 2026 · Updated 18 times

Summary

This study tests a new drug, BHV-1510, in people with advanced solid tumors that have not responded to standard treatments. The trial has two phases: first, finding the safest dose, and second, checking if the drug shrinks tumors when used alone or with another cancer drug (cemiplimab). About 500 adults with incurable, advanced cancers will participate to see if this approach can help control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Site-101

    RECRUITING

    St Louis, Missouri, 63108, United States

  • Site-102

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Site-103

    RECRUITING

    Miami, Florida, 33176, United States

  • Site-104

    RECRUITING

    Dallas, Texas, 75231, United States

  • Site-105

    RECRUITING

    Orlando, Florida, 32827, United States

  • Site-106

    RECRUITING

    West Valley City, Utah, 84119, United States

  • Site-107

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Site-108

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • Site-109

    RECRUITING

    Detroit, Michigan, 48201, United States

  • Site-110

    RECRUITING

    Augusta, Georgia, 30912, United States

  • Site-111

    RECRUITING

    Palo Alto, California, 94304, United States

  • Site-112

    RECRUITING

    La Jolla, California, 92093, United States

  • Site-113

    RECRUITING

    Duarte, California, 91010, United States

  • Site-114

    RECRUITING

    Washington D.C., District of Columbia, 20016, United States

  • Site-115

    RECRUITING

    Tampa, Florida, 33612, United States

  • Site-116

    RECRUITING

    Oklahoma City, Oklahoma, 73117, United States

  • Site-117

    RECRUITING

    New York, New York, 10021, United States

Conditions

Explore the condition pages connected to this study.